Your browser doesn't support javascript.
loading
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
Al-Shamsi, Humaid; Darr, Humaa; Abu-Gheida, Ibrahim; Ansari, Jawaher; McManus, Martine C; Jaafar, Hassan; Tirmazy, Syed Hammad; Elkhoury, Maroun; Azribi, Fathi; Jelovac, Danijela; Doufan, Tarik A; Labban, Abdel Rahman; Basha, Ahmad Ali; Samir, Ahmed; Maarraoui, Aladdin; Al Dameh, Ali; Al-Awadhi, Aydah; Al Haj Ali, Basel; Aboud, Batool; Elshorbagy, Dalia; Trad, Diaa; Abdul Jabbar, Dima; Hamza, Dina; Ashtar, Ed; Dawoud, Emad; Aleassa, Essa M; Khan, Faraz; Iqbal, Faryal; Abdellatif, Hala; Afrit, Mehdi; Masri, Mohamad H; Abuhaleeqa, Mohamed; Alfalasi, Mohamed; Omara, Mohamed; Diab, Mohanad; Latif, Muhammad Farooq; Oner, Muharram; Dreier, Norbert; Almarzouqi, Omar; Singarachari, R A; Bendardaf, Riyad; Alrawi, Sadir; Aldeen, Salman Sray; Rana, Shabeeha; Talima, Soha; Abdelgawad, Tamer; Ahluwalia, Abhinav; Alkasab, Thamir; Madi, Tamer; Alkhouri, Tarek.
Afiliación
  • Al-Shamsi H; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Darr H; Department of Clinical Science, College of Medicine, University of Sharjah.
  • Abu-Gheida I; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Ansari J; Alzahra Hospital, Dubai, United Arab Emirates.
  • McManus MC; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Jaafar H; Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Tirmazy SH; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Elkhoury M; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Azribi F; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Jelovac D; Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Doufan TA; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Labban AR; Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.
  • Basha AA; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Samir A; Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.
  • Maarraoui A; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Al Dameh A; American Hospital, Dubai , United Arab Emirates.
  • Al-Awadhi A; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Al Haj Ali B; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Aboud B; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Elshorbagy D; Breast Cancer Program, The Joh Hopkins Sydney Kimmel Comprehensive Cancer Center Baltimore, MD, USA.
  • Trad D; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Abdul Jabbar D; American Hospital, Dubai , United Arab Emirates.
  • Hamza D; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Ashtar E; Advanced Care Oncology Center, Dubai , United Arab Emirates.
  • Dawoud E; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Aleassa EM; Saudi German Hospital Dubai , Dubai, United Arab Emirates.
  • Khan F; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Iqbal F; Alzahra Hospital, Dubai, United Arab Emirates.
  • Abdellatif H; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Afrit M; Gulf International Cancer Center, Abu Dhabi, United Arab Emirates.
  • Masri MH; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Abuhaleeqa M; American Hospital, Dubai , United Arab Emirates.
  • Alfalasi M; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Omara M; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Diab M; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Latif MF; Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.
  • Oner M; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Dreier N; Oncology Department, Sheikh Khalifa Speciality Hospital, Ras Al-Khaimah, United Arab Emirates.
  • Almarzouqi O; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Singarachari RA; Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.
  • Bendardaf R; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Alrawi S; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Aldeen SS; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Rana S; American Hospital, Dubai , United Arab Emirates.
  • Talima S; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Abdelgawad T; Oncology Department, Dubai Hospital, Dubai, United Arab Emirates.
  • Ahluwalia A; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Alkasab T; Alzahra Hospital, Dubai, United Arab Emirates.
  • Madi T; Emirates Oncology Society, Dubai, United Arab Emirates.
  • Alkhouri T; Department of Oncology, Tawam Hospital, Al-Ain, United Arab Emirates.
Gulf J Oncolog ; 1(32): 71-87, 2020 Jan.
Article en En | MEDLINE | ID: mdl-32342923
ABSTRACT
With cancer being the third leading cause of mortality in the United Arab Emirates (UAE), there has been significant investment from the government and private health care providers to enhance the quality of cancer care in the UAE. The UAE is a developing country with solid economic resources that can be utilized to improve cancer care across the country. There is limited data regarding the incidence, survival, and potential risk factors for cancer in the UAE. The UAE Oncology Task Force was established in 2019 by cancer care providers from across the UAE under the auspices of Emirates Oncology Society. In this paper we summarize the history of cancer care in the UAE, report the national cancer incidence, and outline current challenges and opportunities to enhance and standardize cancer care. We provide recommendations for policymakers and the UAE Oncology community for the delivery of high-quality cancer care. These recommendations are aligned with the UAE government's vision to reduce cancer mortality and provide high quality healthcare for its citizens.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gulf J Oncolog Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gulf J Oncolog Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos